Managing Epilepsy in Women

ABSTRACTPurpose of Review: Caring for a woman with epilepsy requires familiarity with the implications of antiepileptic drugs (AEDs) for pregnancy and contraception as well as an understanding of the effects of female hormones on epilepsy.Recent Findings: AED pregnancy registries and prospective studies of cognitive development continue to confirm that valproate poses a significantly increased risk of structural and cognitive teratogenesis. In contrast, data thus far suggest that lamotrigine and levetiracetam are associated with a relatively low risk for both anatomic and developmental adverse effects, although further studies are needed for these and other AEDs. The intrauterine device is a good contraceptive option for many women with epilepsy as it is highly effective and not subject to the drug-drug interactions seen between hormonal contraception and many AEDs. Hormonal-sensitive seizures are common among women with epilepsy; however, highly effective treatments for refractory catamenial seizures are limited.Summary: Women with epilepsy should be counseled early and regularly about reproductive health as it relates to epilepsy. AED selection for women of childbearing age should take future pregnancies and contraceptive needs into consideration.

[1]  T. Ikeda,et al.  Pregnancy and Delivery , 2017 .

[2]  S. Kochhar.  UK medical eligibility criteria for contraceptive use , 2016 .

[3]  E. Brodtkorb,et al.  Interactions between hormonal contraception and antiepileptic drugs: Clinical and mechanistic considerations , 2015, Seizure.

[4]  T. Tomson,et al.  Major congenital malformations in children of women with epilepsy , 2015, Seizure.

[5]  I. Borthen.  Obstetrical complications in women with epilepsy , 2015, Seizure.

[6]  A. Herzog.  Differential impact of antiepileptic drugs on the effects of contraceptive methods on seizures: Interim findings of the epilepsy birth control registry , 2015, Seizure.

[7]  E. Taubøll,et al.  The impact of seizures on pregnancy and delivery , 2015, Seizure.

[8]  A. Herzog.  Catamenial epilepsy: Update on prevalence, pathophysiology and treatment from the findings of the NIH Progesterone Treatment Trial , 2015, Seizure.

[9]  N. Gilhus,et al.  Depression and anxiety in women with epilepsy during pregnancy and after delivery: A prospective population‐based cohort study on frequency, risk factors, medication, and prognosis , 2015, Epilepsia.

[10]  A. Tardón,et al.  Folic acid supplements during pregnancy and child psychomotor development after the first year of life. , 2014, JAMA pediatrics.

[11]  J. Graham,et al.  The teratogenicity of the newer antiepileptic drugs – an update , 2014, Acta neurologica Scandinavica.

[12]  J. Olsen,et al.  Use of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort study , 2014, BMJ : British Medical Journal.

[13]  M. Eadie,et al.  The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy , 2014, Epilepsia.

[14]  K. Meador,et al.  Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. , 2014, JAMA pediatrics.

[15]  M. Silvestrini,et al.  Seizure course during pregnancy in catamenial epilepsy , 2014, Neurology.

[16]  L. Nashef,et al.  SUDEP and epilepsy‐related mortality in pregnancy , 2014, Epilepsia.

[17]  P. Pennell,et al.  Carbamazepine clearance and seizure stability during pregnancy , 2014, Epilepsy & Behavior.

[18]  S. Teal,et al.  Decreased efficacy of an etonogestrel implant in a woman on antiepileptic medications: a case report , 2014, Journal of Medical Case Reports.

[19]  M. García-Fiñana,et al.  In utero exposure to levetiracetam vs valproate , 2014, Neurology.

[20]  N. Delanty,et al.  Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  P. Pennell,et al.  Model-based lamotrigine clearance changes during pregnancy: clinical implication , 2014, Annals of clinical and translational neurology.

[22]  W. Hauser,et al.  Association Between Topiramate and Zonisamide Use During Pregnancy and Low Birth Weight , 2014, Obstetrics and gynecology.

[23]  E. Gerard.  Women with Epilepsy: Preconception counseling for women with epilepsy , 2014 .

[24]  L. Specchio,et al.  Prospective, case–control study on the effect of pregnancy on seizure frequency in women with epilepsy , 2014, Neurological Sciences.

[25]  N. Gilhus,et al.  Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy , 2014, Journal of Neurology.

[26]  N. Gilhus,et al.  Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy. , 2013, JAMA neurology.

[27]  K. Meador,et al.  Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy , 2013, Epilepsy & Behavior.

[28]  T. Tomson,et al.  Seizure control and treatment changes in pregnancy: Observations from the EURAP epilepsy pregnancy registry , 2013, Epilepsia.

[29]  E. Ben-Menachem,et al.  A prospective, randomized, multicentre trial for the treatment of refractory status epilepticus; experiences from evaluating the effect of the novel drug candidate, NS1209 , 2013, Epilepsy Research.

[30]  Mogens Vestergaard,et al.  Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. , 2013, JAMA.

[31]  L. Wilkins.  Levetiracetam in pregnancy: Results from the UK and Ireland epilepsy and pregnancy registers , 2013, Neurology.

[32]  P. Pennell,et al.  Neuroendocrine considerations in the treatment of men and women with epilepsy , 2013, The Lancet Neurology.

[33]  K. Meador,et al.  Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study , 2013, The Lancet Neurology.

[34]  M. Sperling,et al.  Progesterone vs placebo therapy for women with epilepsy , 2012, Neurology.

[35]  W. Hauser,et al.  Comparative safety of antiepileptic drugs during pregnancy , 2012, Neurology.

[36]  Sanjeev V Thomas,et al.  Predictors of seizures during pregnancy in women with epilepsy , 2012, Epilepsia.

[37]  I. Sinai,et al.  Contraceptive failure in the United States. , 2012, Contraception.

[38]  H. Goodkin,et al.  Wyllie's treatment of epilepsy : principles and practice , 2012 .

[39]  S. Hernández-Díaz,et al.  Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. , 2011, Archives of neurology.

[40]  T. Tomson,et al.  Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry , 2011, The Lancet Neurology.

[41]  J. Messenheimer,et al.  Final results from 18 years of the International Lamotrigine Pregnancy Registry , 2011, Neurology.

[42]  A. Hviid,et al.  Newer-generation antiepileptic drugs and the risk of major birth defects. , 2011, JAMA.

[43]  C. Elger,et al.  Antiepileptic drugs interact with folate and vitamin B12 serum levels , 2011, Annals of neurology.

[44]  K. Curtis,et al.  U S. medical eligibility criteria for contraceptive use, 2010 : adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition , 2010 .

[45]  K. Culwell,et al.  The use of hormonal contraception among women taking anticonvulsant therapy. , 2011, Contraception.

[46]  S. Cousens,et al.  Folic acid to reduce neonatal mortality from neural tube disorders , 2010, International journal of epidemiology.

[47]  T. Trikalinos,et al.  A summary of the Agency for Healthcare Research and Quality's evidence report on breastfeeding in developed countries. , 2009, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[48]  A. Sabers,et al.  Seizure frequency in pregnant women treated with lamotrigine monotherapy , 2009, Epilepsia.

[49]  H. Chiou,et al.  Affect of seizures during gestation on pregnancy outcomes in women with epilepsy. , 2009, Archives of neurology.

[50]  M. Martinez-frias,et al.  TOPIRAMATE IN PREGNANCY: PRELIMINARY EXPERIENCE FROM THE UK EPILEPSY AND PREGNANCY REGISTER , 2009, Neurology.

[51]  A. Pack,et al.  Antiepileptic drugs: Are women aware of interactions with oral contraceptives and potential teratogenicity? , 2009, Epilepsy & Behavior.

[52]  F. Cowan,et al.  Contraception for adolescents. , 2009, Best practice & research. Clinical obstetrics & gynaecology.

[53]  A. Sabers,et al.  Seizure deterioration in women treated with oxcarbazepine during pregnancy , 2009, Epilepsy Research.

[54]  B. Schmitz,et al.  [Fears, knowledge, and need of counseling for women with epilepsy. Results of an outpatient study]. , 2009, Der Nervenarzt.

[55]  E. Horváth-Puhó,et al.  Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case-control study. , 2008, BJOG : an international journal of obstetrics and gynaecology.

[56]  E. Trinka,et al.  Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy , 2008, Journal of Neurology.

[57]  A. Pack,et al.  Reproductive history, sexual behavior and use of contraception in women with epilepsy. , 2008, Contraception.

[58]  S. Stodieck,et al.  Which contraception for women with epilepsy? , 2008, Seizure.

[59]  T. Tomson,et al.  Teratogenic effects of antiepileptic drugs , 2008, Seizure.

[60]  T. Tomson,et al.  Oral Contraceptives Induce Lamotrigine Metabolism: Evidence from a Double‐blind, Placebo‐controlled Trial , 2007, Epilepsia.

[61]  B. Vazquez,et al.  Epilepsy and women’s health issues: Unmet needs—Survey results from women with epilepsy , 2007, Epilepsy & Behavior.

[62]  C. Bearer.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2007 .

[63]  M. Contin,et al.  Variation in Lamotrigine Plasma Concentrations with Hormonal Contraceptive Monthly Cycles in Patients with Epilepsy , 2006, Epilepsia.

[64]  J. Sidhu,et al.  The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. , 2006, British journal of clinical pharmacology.

[65]  B. Irwin,et al.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[66]  J. Detoledo.  Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. , 2006, Neurology.

[67]  A. Auvinen,et al.  Antiepileptic drug use of women with epilepsy and congenital malformations in offspring , 2005, Neurology.

[68]  H. Stefan,et al.  The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients , 1992, Journal of Neurology.

[69]  著者なし.  The History and Stigma of Epilepsy , 2003 .

[70]  M. Bialer,et al.  Effect of Topiramate or Carbamazepine on the Pharmacokinetics of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol in Healthy Obese and Nonobese Female Subjects , 2003, Epilepsia.

[71]  J. Guillebaud,et al.  Observational series on women using the contraceptive Mirena® concurrently with anti-epileptic and other enzyme-inducing drugs , 2002, Journal of Family Planning and Reproductive Health Care.

[72]  V. Hiilesmaa,et al.  Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate , 2002, Neurology.

[73]  E. Mascha,et al.  Acetazolamide in Women with Catamenial Epilepsy , 2001, Epilepsia.

[74]  D. Bergen,et al.  Women with epilepsy. , 2000 .

[75]  W. Rosenfeld,et al.  Effect of Topiramate on the Pharmacokinetics of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol in Patients with Epilepsy , 1997, Epilepsia.

[76]  A. Herzog.  Clomiphene therapy in epileptic women with menstrual disorders , 1988, Neurology.

[77]  J. Cramer,et al.  Treatment of seizures with medroxyprogesterone acetate , 1984, Neurology.

[78]  M. Feely,et al.  CLOBAZAM IN CATAMENIAL EPILEPSY A Model for Evaluating Anticonvulsants , 1982, The Lancet.

[79]  L. Batten.  Upper respiratory disease and the lung. , 1948 .

[80]  Tell Me,et al.  Which? , 1882, The Homoeopathic physician.